Cargando…
COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
Since December 2019, the pandemic caused by coronavirus disease 2019 (COVID-19) raises a real public health problem. COVID-19 appeared in Wuhan (Hubei province) in China. Drugs that have been used in rheumatology for decades seem to be effective in this infection and are for the most part being stud...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256179/ https://www.ncbi.nlm.nih.gov/pubmed/32472461 http://dx.doi.org/10.1007/s10067-020-05189-y |